CVE-2012-5657

Description

The (1) Zend_Feed_Rss and (2) Zend_Feed_Atom classes in Zend_Feed in Zend Framework 1.11.x before 1.11.15 and 1.12.x before 1.12.1 allow remote attackers to read arbitrary files, send HTTP requests to intranet servers, and possibly cause a denial of service (CPU and memory consumption) via an XML External Entity (XXE) attack.

Category

5.0
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.72% Top 30%
Vendor Advisory debian.org Vendor Advisory mandriva.com Vendor Advisory zend.com Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://openwall.com/lists/oss-security/2012/12/20/2 mailing list
http://www.debian.org/security/2012/dsa-2602 vendor advisory
http://www.mandriva.com/security/advisories?name=MDVSA-2013:115 vendor advisory
http://framework.zend.com/security/advisory/ZF2012-05 vendor advisory
http://secunia.com/advisories/51583 third party advisory vendor advisory
http://openwall.com/lists/oss-security/2012/12/20/4 mailing list

Frequently Asked Questions

What is the severity of CVE-2012-5657?
CVE-2012-5657 has been scored as a medium severity vulnerability.
How to fix CVE-2012-5657?
To fix CVE-2012-5657, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2012-5657 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2012-5657 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.